Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001193125-26-027396

Options or other derivatives

  • Chief Executive Officer acquired 629,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tak Paul Peter · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-26 Grant or award : show line 1 in the form Stock Option (Right to Buy) +629,000 629,000 D
Loading xslF345X05/ownership.xml…